Improve the quality of applications

Through use of reflexive questioning that supports co-morbid conditions, eValuate guides agents in real-time to ask the right questions, ensuring all relevant applicant information is captured. By doing so, it improves the quality of applications submitted so your underwriters can focus on the cases you want them to.

Single and multi-carrier

eValuate comes in single and multi-carrier versions, helping improve risk selection regardless of distribution channel.

eValuate can:

• Support agent/agency and consumer processing
• Reduce cycle-time
• Increase placement ratio
• Improve staff productivity
• Enhance customer experience

eValuate supports:

• Multiple Impairments
• Co-Morbid Conditions
• Carrier Specific Controlled Rules
• Proprietary Underwriting Guidelines

eValuate delivers:

The Medix App is a personal, holistic, one-stop medical command center that puts patients at the helm of their unique health journeys.

Reduced underwriting and administrative cost Greatly reduces the number of quick quotes and informal submissions Real-time results as data is entered

Ensure your applications have the best chance of turning into placed policies!  Watch this video to learn more. eValuate is a Service Mark of the Paperless Solutions Group

Latest Updates

Carrier Collaboration & Platform Accuracy
PSG works closely with carriers to ensure eValuate delivers accurate, real-time field underwriting assessments for both simple and complex medical risks. Ongoing rules enrichment continues to expand the platform’s ability to produce precise preliminary quotes across more impairments and comorbidities.

Product Highlights

New Features

• Carriers can now provide optional “infotips,” offering added guidance to agencies via an “i” hover icon.
• Agencies may select which carrier quotes appear in the PDF Case Summary.
• Required fields are highlighted, with pop-up alerts when left incomplete.
• Rules can be differentiated by face amount for more targeted results.

Rules Enrichment
2025 has delivered significant rules expansion, adding detailed guidelines for multiple carriers and improving logic for numerous conditions, including comorbidities, debits, and credits. Recent updates include:

• Enhanced rules for gestational diabetes, pre-diabetes, Type 1 & Type 2 diabetes (including A1C and cholesterol credits), prostate cancer, and sleep apnea.
• New smoking-related questions to refine last-use details.
• Integration of Nationwide’s Field Guide and updates to Principal’s Field Guide.
• Expanded rules support for Lincoln, SBLI, Pacific Life, Corebridge, and Mutual of Omaha.
• New commitment from Prudential to add their detailed guidelines.

Product Spotlight

eValuate now applies strengthened diabetes rules—including comorbidities and credits—to guide agents toward the best class and carrier, improving efficiency for agents, BGAs, and carriers while increasing placement success.

PSG will continue enhancing eValuate by expanding and refining impairment support. PSG acknowledges the contributions of carrier underwriting partners, medical directors, agency customers, and the eValuate Advisory Board for their ongoing insight and collaboration.